Get the Stockscreener App
4.72
1.29%
0.06
After Hours:
4.77
0.05
+1.06%
Taysha Gene Therapies Inc Stock (TSHA) Forecast
The Taysha Gene Therapies Inc (TSHA) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $9.0958, representing a +92.71% increase from the current price of $4.72. The highest analyst price target is $9.1399, and the lowest is $9.0518.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month TSHA Price Target
Average 7.9947
(+69.38% Upside)
Is Taysha Gene Therapies Inc (TSHA) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 46.30 | Neutral |
| STOCH(9,6) | 28.53 | Neutral |
| STOCHRSI(14) | 66.96 | Neutral |
| MACD(12,26) | -0.1481 | Sell |
| ADX(14) | 15.38 | Neutral |
| William %R | -58.45 | Neutral |
| CCI(14) | 3.1666 | Neutral |
Buy: 0
Sell: 1
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
4.695
Buy
|
4.6941
Buy
|
| MA20 |
4.827
Sell
|
4.8211
Sell
|
| MA50 |
5.0502
Sell
|
4.864
Sell
|
| MA100 |
4.6004
Buy
|
4.5177
Buy
|
| MA200 |
3.5928
Buy
|
3.8311
Buy
|
Buy: 6
Sell: 4
Neutral: 0
Summary: Buy
According to our latest analysis, TSHA could be considered a Neutral, with 17 technical analysis indicators signaling 6 Buy signals, 5 signaling Sell signals and 6 Neutral signals. This suggests that investors should exercise caution when entering new positions on TSHA, as the market is likely to remain volatile in the near term.
- RSI (Relative Strength Index): The RSI(14) value of 46.3 indicates that TSHA is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 28.53 indicates that TSHA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 66.96 indicates that TSHA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 15.38 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 3.1666 indicates that TSHA is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term TSHA price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Taysha Gene Therapies Inc financial reports and earnings history, Taysha Gene Therapies Inc (TSHA) stock could reach $19.26 by 2030, $16.43 by 2040 and $87.00 by 2050. See the projected annual prices until 2050 of the Taysha Gene Therapies Inc stock below:
- Taysha Gene Therapies Inc (TSHA) is expected to reach an average price of $24.00 in 2035, with a high prediction of $24.28 and a low estimate of $24.17. This indicates an $408.52% rise from the last recorded price of $4.72.
- Taysha Gene Therapies Inc (TSHA) stock is projected to chart a bullish course in 2040, with an average price target of $16.16, representing an $242.36% surge from its current level. The forecast ranges from a conservative $16.38 to a sky-high $16.43.
- Our analysts predict Taysha Gene Therapies Inc (TSHA) to jump 1,564% by 2045, soaring from $80.52 to an average price of $78.55, potentially reaching $79.36. While $80.52 is the low estimate, the potential upside is significant.
- Taysha Gene Therapies Inc (TSHA) stock is expected to climb by 2050, reaching an average of $85.92, a $1,720% jump from its current level. However, a wide range of estimates exists, with high and low targets of $87.00 and $86.04, respectively, highlighting the market's uncertainty.
Taysha Gene Therapies Inc Stock (TSHA) Year by Year Forecast
Taysha Gene Therapies Inc Stock (TSHA) Price Forecast for 2026
The predicted value for Taysha Gene Therapies Inc (TSHA) in 2026 is set at an average of $7.7582. Estimates vary from a peak of $9.1399 to a trough of $6.3765, indicating an +64.37% surge from the present price of $4.72.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| March, 2026 | $8.4318 | $9.0518 | $9.1399 | +78.64% |
| April, 2026 | $6.9015 | $7.8396 | $8.4577 | +46.22% |
| May, 2026 | $6.6852 | $6.9032 | $6.7574 | +41.64% |
| June, 2026 | $7.489 | $7.0411 | $7.359 | +58.66% |
| July, 2026 | $8.2986 | $7.4308 | $8.0086 | +75.82% |
| August, 2026 | $8.1624 | $8.3846 | $8.2765 | +72.93% |
| September, 2026 | $7.1421 | $7.3521 | $8.0383 | +51.32% |
| October, 2026 | $6.9958 | $7.0058 | $7.048 | +48.22% |
| November, 2026 | $6.4996 | $6.8496 | $6.8075 | +37.70% |
| December, 2026 | $7.3092 | $6.8755 | $7.1533 | +54.86% |
Taysha Gene Therapies Inc Stock (TSHA) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Taysha Gene Therapies Inc (TSHA) is $4.6381, with a high forecast of $7.1452 and a low forecast of $2.1311. This indicates an -1.73% decrease from the last price of $4.72.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $6.963 | $7.063 | $7.1452 | +47.52% |
| February, 2027 | $6.9091 | $7.0434 | $7.0111 | +46.38% |
| March, 2027 | $6.5806 | $6.6164 | $6.7447 | +39.42% |
| April, 2027 | $6.2513 | $6.2756 | $6.4106 | +32.44% |
| May, 2027 | $5.9539 | $5.9539 | $6.076 | +26.14% |
| June, 2027 | $5.5156 | $5.5736 | $5.8108 | +16.86% |
| July, 2027 | $3.9373 | $4.5173 | $5.3895 | -16.58% |
| August, 2027 | $1.8811 | $2.1311 | $3.0633 | -60.15% |
| September, 2027 | $2.8408 | $2.487 | $2.3308 | -39.81% |
| October, 2027 | $2.2845 | $2.5195 | $2.5717 | -51.60% |
| November, 2027 | $2.6683 | $2.7083 | $2.6023 | -43.47% |
| December, 2027 | $2.2379 | $2.4079 | $2.4942 | -52.59% |
Taysha Gene Therapies Inc Stock (TSHA) Price Forecast for 2028
In 2028, Taysha Gene Therapies Inc (TSHA) is projected to reach an average price of $8.959, with a high projection of $17.88 and a low estimate of $0.0367. This indicates an +89.81% rise from the last price of $4.72.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $2.1917 | $2.2498 | $2.1158 | -53.57% |
| February, 2028 | $1.4254 | $1.9254 | $1.9476 | -69.80% |
| March, 2028 | $0.6151 | $0.0367 | $0.4667 | -86.97% |
| April, 2028 | $0.3611 | $0.0411 | $0.8211 | -92.35% |
| May, 2028 | $17.56 | $0.0633 | $15.17 | +272.03% |
| June, 2028 | $18.49 | $19.25 | $17.75 | +291.68% |
| July, 2028 | $17.18 | $18.36 | $17.88 | +264.09% |
| August, 2028 | $10.57 | $16.24 | $15.87 | +124.03% |
| September, 2028 | $6.2918 | $7.3818 | $8.4787 | +33.30% |
| October, 2028 | $5.6893 | $7.3275 | $5.8256 | +20.54% |
| November, 2028 | $14.05 | $10.93 | $10.69 | +197.64% |
| December, 2028 | $11.06 | $13.20 | $14.44 | +134.24% |
Taysha Gene Therapies Inc Stock (TSHA) Price Forecast for 2029
The 2029 price forecast for Taysha Gene Therapies Inc Stock (TSHA) is $14.58 on average, with a high prediction of $20.01 and a low estimate of $9.1431. This represents an +208.82% increase from the previous price of $4.72.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $12.45 | $11.64 | $12.38 | +163.68% |
| February, 2029 | $7.6431 | $9.1431 | $10.77 | +61.93% |
| March, 2029 | $11.42 | $9.4349 | $11.38 | +141.96% |
| April, 2029 | $14.16 | $13.69 | $13.83 | +199.96% |
| May, 2029 | $11.62 | $12.03 | $13.54 | +146.13% |
| June, 2029 | $11.92 | $11.15 | $10.22 | +152.65% |
| July, 2029 | $14.13 | $12.04 | $11.54 | +199.42% |
| August, 2029 | $16.34 | $14.19 | $15.52 | +246.22% |
| September, 2029 | $13.34 | $15.14 | $15.58 | +182.61% |
| October, 2029 | $19.59 | $15.60 | $18.03 | +315.01% |
| November, 2029 | $19.48 | $19.53 | $19.13 | +312.63% |
| December, 2029 | $20.45 | $20.02 | $20.01 | +333.34% |
Taysha Gene Therapies Inc Stock (TSHA) Price Forecast for 2030
Taysha Gene Therapies Inc Stock (TSHA) is expected to reach an average price of $18.32 in 2030, with a high forecast of $21.05 and a low forecast of $15.59. This signifies an +288.14% surge from the last price of $4.72.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $18.99 | $19.04 | $19.26 | +302.39% |
| February, 2030 | $21.00 | $19.36 | $19.80 | +344.92% |
| March, 2030 | $21.31 | $20.92 | $21.03 | +351.44% |
| April, 2030 | $20.51 | $20.64 | $21.05 | +334.44% |
| May, 2030 | $18.21 | $18.45 | $18.96 | +285.91% |
| June, 2030 | $17.70 | $17.94 | $17.41 | +275.05% |
| July, 2030 | $17.54 | $17.91 | $18.01 | +271.65% |
| August, 2030 | $18.49 | $18.04 | $18.24 | +291.72% |
| September, 2030 | $17.90 | $17.97 | $18.25 | +279.17% |
| October, 2030 | $16.57 | $16.78 | $17.34 | +250.97% |
| November, 2030 | $16.02 | $16.14 | $16.26 | +239.48% |
| December, 2030 | $15.49 | $15.59 | $15.66 | +228.20% |
1.22%
2.07%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):